Anavex is a pharmaceutical company engaged in the development of drug candidates.
Quote | Anavex Life Sciences Corp. (NASDAQ:AVXL)
|Last Trade Date Time:||06/09/2023 03:00:00 am|
News | Anavex Life Sciences Corp. (NASDAQ:AVXL)
2023-06-06 21:00:06 ET Summary Blarcamesine, a sigma-1 receptor agonist, may be a more effective antioxidant than Aricept and galantamine in treating Alzheimer's disease. If granted accelerated approval by the FDA, Anavex's stock value is expected to rise significantly. Anavex...
NEW YORK, June 06, 2023 (GLOBE NEWSWIRE) -- Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage biopharmaceutical company developing differentiated therapeutics for the treatment of neurodegenerative and neurodevelopmental disorders ...
Message Board Posts | Anavex Life Sciences Corp. (NASDAQ:AVXL)
|Alzheimer's Association International Conference||georgejjl||investorshub||06/10/2023 4:15:31 AM|
|Sorry for falling on that quick P&D scheme.||jav0033||investorshub||06/10/2023 3:42:03 AM|
|Expect complete Anavex Phase 2b/3 Alzheimer's trial results||georgejjl||investorshub||06/10/2023 3:38:33 AM|
|My reference to a "liquidity event" was related||kevindenver||investorshub||06/10/2023 2:55:53 AM|
|No, the reality is --- some people bought||Anshu2||investorshub||06/10/2023 2:53:50 AM|
Anavex Life Sciences Corp. Company Name:
AVXL Stock Symbol:
Anavex Life Sciences Corp. Website:
News, Short Squeeze, Breakout and More Instantly...